Instrument Inactif

Autres langues Thoratec Corporation

Actions

US8851753074

Equipement et technologie médicale avancés

Cours en clôture Nasdaq
- ^USD	-

22/07/15	St Jude Medical : Médical-St. Jude rachète Thoratec pour $3,4 milliards	RE
21/07/15	BOURSE-Thoratec bondit à Wall Street sur des spéculations d'OPA	RE

Autres langues

07/10/15	Thoratec : Shareholders Approve St. Jude Medical's Acquisition Of Thoratec
06/10/15	Thoratec : Highlights Clinical Events From The European Association For Cardio-Thoracic Surgery Conference
27/09/15	Thoratec : HeartMate 3™ CE Mark Trial Meets Primary Endpoint
27/09/15	Thoratec : HeartMate 3(TM) CE Mark Trial Meets Primary Endpoint
23/09/15	Thoratec : Healthcare Sector Equities under Review -- Baxter Intl., Brookdale Senior Living, Envision Healthcare Holdings, Unilife, and Thoratec
14/09/15	Thoratec : Issues Voluntary Device Correction
04/09/15	Thoratec : Announces Start Of Shield II™ U.S. Clinical Trial
04/09/15	Thoratec : Announces Start Of Shield II(TM) U.S. Clinical Trial
21/08/15	Thoratec : Announces End Of "Go Shop" Period
04/08/15	Thoratec : reg; Reports Second Quarter 2015 Results
29/07/15	Thoratec : Receives CE Mark Approval for its HeartMate PHP(TM) Pump - Report on Thoratec Corp.
24/07/15	Thoratec : Ryan & Maniskas, LLP : Announces Investigation of Thoratec Corp.
23/07/15	Thoratec : Stockholders Encouraged to Contact Securities Law Firm about Takeover
22/07/15	Thoratec : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Thoratec Corporation Stockholders
22/07/15	Thoratec : Announces Preliminary Second Quarter Revenue
13/07/15	Thoratec : Receives CE Mark Approval For HeartMate PHP™
13/07/15	Thoratec : Receives CE Mark Approval For HeartMate PHP(TM)
06/07/15	Thoratec : Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial
06/07/15	Thoratec : Announces First HeartMate 3(TM) Implant in European Less Invasive Surgical Trial
26/05/15	Thoratec : Presentation At Goldman Sachs Healthcare Conference To Be Webcast
26/05/15	Thoratec : Receives Conditional FDA Approval For The Shield II U.S. Clinical Trial For HeartMate PHP
07/05/15	Thoratec : reg; Reports First Quarter 2015 Results
01/05/15	Thoratec : Announces Addition To Senior Management Team
30/04/15	Thoratec : Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast
20/04/15	Thoratec : Schedules First Quarter Conference Call, Webcast